Initial exploration has defined a >35km² ring-shaped magnetic anomaly exceeding 6.5km along its major axis, while shallow drilling has confirmed ra...
Wolfe Research analyst Emmanuel Rosner initiates coverage on Ferrari (NYSE:RACE) with a Outperform rating.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with r...
Baird analyst David Koning maintains Mastercard (NYSE:MA) with a Outperform and raises the price target from $660 to $680.
Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease ...
onsemi’s Fab Right manufacturing strategy focuses on continuous optimization of manufacturing footprint and directs resources to the most competitive,...
Companies Reporting Before The Bell Companies Reporting After The Bell • Kura Sushi USA (NASDAQ:KRUS) is expected to report quarterly loss at $0.03 pe...
Baird analyst David Koning maintains Genpact (NYSE:G) with a Neutral and lowers the price target from $45 to $38.
AMD stock drops 4% premarket amid tech sector pullback. Is this a buying opportunity? Get the latest AMD market analysis.
Recombinant vector vaccine protects chickens against Newcastle disease and Marek's disease in a single doseZoetis Inc. (NYSE:ZTS) today announced ...
Across these AAIC presentations, we are showing how AC Immune’s Morphomer®-based small molecule approach has generated differentiated therapeutic and ...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to advance its TEV-’408, an investigational anti-interleukin-15 monocl...
Plugs GenEco™ PEM electrolyzers to power Australia's largest renewable hydrogen project and first Hydrogen Headstart recipient to reach FIDProject...
Headwaters ARC is designed as a significantly larger and more expandable platform than the Company’s previously announced Sierra ARC project. Aqua Met...
Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient's pain before ...
B of A Securities analyst Ebrahim Poonawala maintains State Street (NYSE:STT) with a Neutral and raises the price target from $160 to $190.
Top Wall Street analysts upgraded FSLR, META, WM, NET, and REGN stocks. Check out analyst ratings page for more details and opinions.
In Phase 3 trial in obesity/overweight in China, HRS-7535 achieved a mean weight loss of up to 10.9% at Week 44 and a mean weight loss of up to 11.1% ...
US equity markets were mixed over last week, with broad index performance modestly positive but sector leadership uneven. The S&P 500 ETF gained 0.56%...
Loading...